VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Cuthbert Simpkins, MD, FACS
Vivacelle Bio
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dignity Health
Chandler, Arizona, United States
- University of Arizona
Tucson, Arizona, United States
- Umd Shock Trauma
Baltimore, Maryland, United States
- Adventist Health Care
Silver Spring, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Truman Medical Center
Kansas City, Missouri, United States
- Mount Sinai Hospital
New York, New York, United States
- Einstine Medical Center
East Norriton, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Feb 2020
- Primary completion
- 31 Dec 2023
- Completion
- 31 Dec 2023
- Last update posted
- 23 Oct 2023
- Registered enrollment
- 20
- Registry id
- NCT04257136
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.